TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review

被引：10

作者：

Mosca, Marta ^{[1
]}

Tani, Chiara ^{[1
]}

Filice, Maria Elena ^{[3
]}

Carli, Linda ^{[1
]}

Delle Sedie, Andrea ^{[2
]}

Vagnani, Sabrina ^{[1
]}

Della Rossa, Alessandra ^{[2
]}

Baldini, Chiara ^{[1
]}

Bombardieri, Stefano ^{[1
]}

机构：

[1] Univ Pisa, Dept Clin & Expt Med, Rheumatol Unit, I-56126 Pisa, Italy

[2] Azienda Osped Univ Pisana, Rheumatol Unit, Pisa, Italy

[3] Azienda Osped Univ Pisana, Pathol Unit, Pisa, Italy

来源：

MODERN RHEUMATOLOGY | 2015年 / 25卷 / 04期

关键词：

Anti-TNF therapy; Joint involvement; Systemic lupus erythematosus treatment targets; NECROSIS-FACTOR-ALPHA; TISSUE DISEASES UCTD; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; AUTOIMMUNE-DISEASES; OPEN-LABEL; INFLIXIMAB; EFFICACY; ETANERCEPT; SAFETY; THERAPY;

D O I：

10.3109/14397595.2013.844306

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Joint involvement is a common manifestation of systemic lupus erythematosus (SLE) and is described as a non-erosive mild synovitis. However some SLE patients may present a more severe joint involvement requiring aggressive therapy. We describe the case of a SLE patient with a severe arthritis unresponsive to methotrexate, successfully treated with anti-TNF-alpha drug as induction therapy and we report the results of a systematic literature review on the use of TNF-alpha inhibitors in SLE.

引用

页码：642 / 645

页数：4

共 50 条

[1] The use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now?
Lorenzo-Vizcaya, Ana
Isenberg, David A.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (05) : 639 - 647
[2] Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus
Ferreira, G. A.
Teixeira, A. L.
Calderaro, D. C.
Sato, E. I.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (01) : 42 - 48
[3] Lupus enteritis as initial manifestation of systemic lupus erythematosus. Report of one case
Barrera O, Manuel
Barrera M, Rodrigo
De La Rivera, Matias, V
Vela U, Javier
Monckeberg F, Gustavo
REVISTA MEDICA DE CHILE, 2017, 145 (10) : 1349 - 1352
[4] TNF-alpha Blockade with Infliximab in a Patient with Lupus Erythematosus Profundus
Guenther, Claudia
Aringer, Martin
Lochno, Marlene
Kaemmerer, Eva
Bauer, Andrea
Wozel, Gottfried
Meurer, Michael
ACTA DERMATO-VENEREOLOGICA, 2012, 92 (04) : 401 - 403
[5] Acquired Inhibitors to Coagulation Factors in a Male Patient with Systemic Lupus Erythematosus: A Case Report and Review of the Literature
Erdem, Ozgur
Ayyildiz, Orhan
Aybak, Mehmet
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2012, 22 (02): : 120 - 124
[6] Systemic lupus erythematosus complicated by Crohn's disease: a case report and literature review
Yamashita, Hiroyuki
Ueda, Yo
Kawaguchi, Hoshimi
Suzuki, Akitake
Takahashi, Yuko
Kaneko, Hiroshi
Kano, Toshikazu
Mimori, Akio
BMC GASTROENTEROLOGY, 2012, 12
[7] Systemic lupus erythematosus and contraception: A systematic literature review
Gensous, N.
Doassans-Comby, L.
Lazaro, E.
Duffau, P.
REVUE DE MEDECINE INTERNE, 2017, 38 (06): : 358 - 367
[8] Telitacicept for Recalcitrant Cutaneous Manifestations of Systemic Lupus Erythematosus: A Case Report and Review of the Literature
Ma, Xinyue
Fu, Xiaoying
Cui, Beibei
Lin, Hui
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 258 (03) : 219 - 223
[9] Incidence of histoplasmosis in patients receiving TNF-alpha inhibitors: A systematic review and meta-analysis
Cipolat, Murillo M.
Rodrigues, Debora R. R.
Brenol, Claiton V.
Pasqualotto, Alessandro C.
Falci, Diego R.
MEDICINE, 2023, 102 (49) : E36450
[10] Tuberculous sacroiliitis in a patient with systemic lupus erythematosus: a case report and literature review
Calle, E.
Gonzalez, L. A.
Munoz, C. H.
Jaramillo, D.
Vanegas, A.
Vasquez, G.
LUPUS, 2018, 27 (08) : 1378 - 1382

← 1 2 3 4 5 →